Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PSEC vs BCSF: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PSEC Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 5–5 Matrix Metrics)

PSEC Overall Winner 6-Pillar Tally: PSEC 3 – 2 BCSF (1 Tie) Matrix Metrics: PSEC 5 – 5 BCSF

As of Nov 16, 2026, Prospect Capital Corporation (PSEC) is the stronger overall head-to-head candidate over Bain Capital Specialty Finance, Inc. (BCSF) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). PSEC carries a Unified Composite Score of 46.7/100 (HOLD) at $1.35 (4.2x Forward P/E, 71.1% operating margin), whereas BCSF carries 39.6/100 (SELL) at $10.86 (8.1x Forward P/E, 76.8% operating margin).

  • Technical & Structure Timing Caution: PSEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.9); meanwhile BCSF is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PSEC vs BCSF
PSEC NASDAQ Head-to-Head Winner
Prospect Capital Corporation
Institutional Equity
$1.35
-7.54% 1D
Market Cap $782.6M
TTM Revenue $634M
Forward P/E 4.2x
Beta / 30D Vol 0.84β · 62% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -14.8%), weak momentum, RSI 33
RSI-14: 32.9 · SMA20: $1.49 · SMA50: $1.80
BCSF NYSE
Bain Capital Specialty Finance, Inc.
Institutional Equity
$10.86
-1.94% 1D
Market Cap $717.4M
TTM Revenue $257M
Forward P/E 8.1x
Beta / 30D Vol 0.48β · 26% Vol
Unified Composite Score
39.6 / 100 SELL
Tech 39.0 Fund 44.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -5.0%) with fading momentum, RSI 49
RSI-14: 48.6 · SMA20: $10.75 · SMA50: $10.90

6-Pillar Scorecard Institutional Category Breakdown (PSEC 3 – 2 BCSF)

Columns: Metric · PSEC · BCSF
1. Valuation Multiples PSEC
Forward P/E 4.2x 8.1x
Trailing P/E 9.4x 11.5x
PEG Ratio 1.55x 1.05x
EV / Revenue 1.2x 2.8x
2. Growth & Scale PSEC
Revenue Growth (YoY) -3.7% -10.9%
Earnings Growth (YoY) -78.2% -10.7%
TTM Revenue (USD) $634M $257M
Market Cap $782.6M $717.4M
3. Profitability & Quality BCSF
Gross Margin 100.0% 100.0%
Operating Margin 71.1% 76.8%
Net Profit Margin 8.5% 24.1%
Return on Equity (ROE) 1.2% 5.6%
4. Balance Sheet & Cash Flow BCSF
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $5.36 Book/Sh · 1.2% ROE $16.49 Book/Sh · 5.6% ROE
Dividend Yield 34.67% 14.91%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 26.1% (<1st %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Distribution
6. R&D & Supply-Chain Moat PSEC
OpEx & R&D Intensity 28.9% of Rev ($183M) 23.2% of Rev ($60M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Asset Management Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PSEC (5) vs BCSF (5)
Institutional Metric PSEC BCSF Criterion Row Edge
Market Capitalization
Scale
$782.6M $717.4M Larger Scale PSEC
Trailing P/E Ratio
Valuation
9.4x 11.5x Lower Multiple PSEC
Forward P/E Ratio
Valuation
4.2x 8.1x Lower Multiple PSEC
Revenue Growth (YoY)
Growth
-3.7% -10.9% Higher Growth PSEC
Operating Margin (TTM)
Profitability
71.1% 76.8% Higher Margin BCSF
Net Profit Margin
Profitability
8.5% 24.1% Higher Margin BCSF
Return on Equity (ROE)
Capital Efficiency
1.2% 5.6% Higher ROE BCSF
52-Week Range Position
Momentum
3% ($1–$3) 18% ($10–$15) Stronger Trend BCSF
Beta / 30D Volatility
Risk Regime
0.84β · 62% Vol 0.48β · 26% Vol Lower Realized Risk BCSF
Unified Institutional Score
Composite Signal
46.7 / 100 (HOLD) 39.6 / 100 (SELL) Higher Composite PSEC
Trailing 12M Revenue (USD)
Operating Scale
$634M $257M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.55x PEG · 1.2x EV/Rev 1.05x PEG · 2.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($5.36 Book/Sh · 1.2% ROE) N/A ($16.49 Book/Sh · 5.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BCSF +21.43 pp
PSEC: -15.63% · BCSF: +5.8%
3M Horizon BCSF +29.93 pp
PSEC: -40.0% · BCSF: -10.07%
6M Horizon BCSF +20.97 pp
PSEC: -38.36% · BCSF: -17.39%
1Y Horizon BCSF +29.7 pp
PSEC: -51.44% · BCSF: -21.74%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PSEC vs BCSF. Trailing 12-month operating profitability (PSEC 71.1% vs BCSF 76.8%) and valuation multiples (PSEC 4.2x vs BCSF 8.1x Forward P/E) are benchmarked directly in Pillar 4 below.

PSEC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$634M
Gross Margin100.0%
Op. Margin71.1%
ROE / Fwd P/E1.2% · 4.2x
BCSF ADR TTM Benchmark FX-Normalized USD
TTM Revenue$257M
Gross Margin100.0%
Op. Margin76.8%
ROE / Fwd P/E5.6% · 8.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PSEC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 26.1%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PSEC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BCSF UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BCSF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PSEC Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $782.6M market capitalization and 71.1% operating margin.
OpEx & R&D Reinvestment 28.9% of Rev ($183M)
90D Engineering Disclosures 0 Published
BCSF Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $717.4M market capitalization and 76.8% operating margin.
OpEx & R&D Reinvestment 23.2% of Rev ($60M)
90D Engineering Disclosures 0 Published

Investor FAQ PSEC vs BCSF Key Questions & Quantitative Answers

As of Nov 16, 2026, Prospect Capital Corporation (PSEC) is the stronger overall head-to-head candidate over Bain Capital Specialty Finance, Inc. (BCSF) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). PSEC carries a Unified Composite Score of 46.7/100 (HOLD) at $1.35 (4.2x Forward P/E, 71.1% operating margin), whereas BCSF carries 39.6/100 (SELL) at $10.86 (8.1x Forward P/E, 76.8% operating margin). Technical & Structure Timing Caution: PSEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.9); meanwhile BCSF is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PSEC leads the Growth & Scale pillar: PSEC posts -3.7% YoY revenue growth and -78.2% YoY earnings growth on $634M TTM revenue (100.0% gross margin, 71.1% operating margin), compared with BCSF at -10.9% YoY revenue growth and -10.7% YoY earnings growth on $257M TTM revenue (100.0% gross margin, 76.8% operating margin). On trailing 12-month operating scale, PSEC generates $634M in USD-normalized revenue versus $257M for BCSF. In operating R&D and SG&A reinvestment, PSEC deploys 28.9% of Rev ($183M) (0 90-day corporate R&D disclosures) versus 23.2% of Rev ($60M) (0 disclosures) for BCSF.

PSEC screens cheaper on headline valuation multiples. PSEC trades at 4.2x Forward P/E, 9.4x Trailing P/E, 1.55x PEG, and 1.2x EV/Revenue (unreported cash flow margin), whereas BCSF trades at 8.1x Forward P/E, 11.5x Trailing P/E, 1.05x PEG, and 2.8x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PSEC (1.2% ROE) versus BCSF (5.6% ROE) capital efficiency.

In options market volatility and institutional positioning, PSEC carries 26.1% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.84β · 62% Vol realized risk). By comparison, BCSF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.48β · 26% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.